Arcus Biosciences
Arcus researches, develops and commercializes molecular based immunotherapies for the treatment of cancer.
Business Model:
Revenue: $432.8M
Employees: 201-500
Industries / Tags:
Detailed Arcus Biosciences Information
Geographic Data
Address: 3928 Point Eden Way
City: Hayward
State: CA
Zip: 94545
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$220M
Raised Total:$347M
Social
Metrics
1,906,786Website Global Rank
11,370Website Monthly Traffic
Twitter Followers
Description
Arcus researches, develops and commercializes molecular based immunotherapies for the treatment of cancer.
Contact Phone:
+15106946200
Contact Email:
Arcus Biosciences went public on 3/14/2018 on the NYSE
Listed Exchange:
NYSE
IPO Date:
3/14/2018
Ticker Symbol:
RCUS
IPO Price:
$15/share
Amount Raised:
$120M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
